Spreadsheet: e33db9ca-6d79-4007-a21e-e403a0e26225
Sheet: LFA_Procurement Info_4

[NAME] On-going Progress Review and Disbursement Recommendation
PROGRESS UPDATE PERIOD
Grant number:
Progress Update - Reporting Period: |  | Cycle: |  |  | Number:
Progress Update - Period Covered: |  | Beginning Date: |  |  | End Date:
Progress Update - Number:
Section 4: LFA-verified Procurement and Supply Management Information
 |  | PR's response | LFA's response | LFA Comments/Analysis
1a.  Has the PR updated the Price Quality Reporting (PQR) with the required information on the pharmaceuticals and health products received during the period covered by this PU/DR’ (if applicable)?  (If health products procurement information has not been entered into the PQR, please explain why in comments box) |  |  | N/A | Health products totaling Eur 64,081 were procured through VPP during the period.  The health products procured were mainly HBC kits and do not relate to the 6 PQR categories in the table below.
1b.  Value of Pharmaceuticals and Health Products in the PQR (6 categories only)
(!) This table is included in the PU/DR form with the aim to improve completeness of information in the PQR system and not for comparing PQR amounts vis-à-vis expenditure per se. NB: PQR and expenditure amounts on health products may not be equal due to a timelag between payments and delivery of pharmaceuticals/health products. (!)  For further guidance on PQR data entry, please refer to the guidelines.
Reporting Currency
PQR Product Categories |  | Value of  products received during reporting period | Value of products entered by the PR and verified as correct by the LFA in the PQR during reporting period | [NAME] | Reason for [NAME] |  | Cumulative value of  products received since Jan 2011 | Cumulative value of products verified as correct by the LFA in the PQR since Jan 2011 | [NAME] | Reason for [NAME]
1. Anti-malaria medicines
2. Bed nets
3. Rapid Diagnostic Tests
4. Condoms
5. Anti-retrovirals
6. Anti-TB Medicines
Total
2. Based on best information available to the LFA, are there any risks of drug stockout at the central level in the next period of implementation?  (If yes, please explain in comments box)  ! This section should be completed by the LFA based on best information on stock levels at the central level available to the LFA and should not require dedicated visits for on-site checks of stocks. |  |  | Yes | • The stock of male condoms as at 28 February 2011 were 488,160 pieces.  • Monthly consumption in 2010 was approximately 70,898 pieces.  • Taking the monthly consumption rate into consideration, there is a risk of stock out as the quantities on hand will only be adequate to cater for the next 6-7 months in 2011. The additional requirement for the remaining months in 2011 is approximately 212,694 pieces. However there is no budget in year for the procurement of condoms. In view of this, PR in collaboration with NAS should ensure that they explore other avenues to raise funds for the procurement of the additional condom requirements for Year 2 of program implementation.
3.  PR comments on issues related to the procurement and supply management of pharmaceuticals and health products |  |  |  |  | LFA analysis on issues related to the procurement and supply management of pharmaceuticals and health products
 |  |  |  |  | The stock of male condoms as at 28 February 2011 is not considered adequate to cater for the whole of 2011.   Delays in the delivery of HBC kits affects program implementation.  Religious and cultural opposition to the use of condoms in some sects of the community poses challenges to the distribution and use of condoms in these communities.